Target intelligence / Profile preview

Red blood cell membrane lipid composition

Molecular classification
Other
01

Overview

Red blood cell (RBC) membrane lipid composition refers to the complex and precisely regulated distribution of phospholipids, cholesterol, and glycolipids within the erythrocyte bilayer. This lipid architecture is a primary determinant of membrane fluidity and cellular deformability, properties essential for RBCs to navigate microcapillaries that are significantly narrower than their own diameter. The maintenance of this composition is vital for efficient gas exchange, osmotic stability, and the protection of internal hemoglobin from oxidative stress. Alterations in RBC membrane lipids, such as changes in the cholesterol-to-phospholipid ratio or fatty acid saturation levels, are significant pathological markers in diseases including sickle cell anemia, diabetes mellitus, cardiovascular disease, and chronic heart failure. Pharmacological agents like omega-3 fatty acids are used to modulate these lipid profiles to improve membrane integrity and blood rheology. Conversely, certain treatments like interferon-ribavirin therapy can cause adverse lipid alterations, leading to clinical complications such as hemolytic anemia.

Other names
Erythrocyte membrane lipidomeRBC membrane lipid profileRBC membrane fatty acid compositionErythrocyte membrane lipid composition
02

Mechanism of action

Modification of the lipid bilayer to restore membrane fluidity, reduction of lipid peroxidation through antioxidant activity, and alteration of the cholesterol-to-phospholipid ratio to enhance cellular deformability.

03

Biological functions

Membrane fluidityCellular deformabilityGas exchangeCell shape maintenanceOsmotic stabilityCellular signaling
04

Disease associations

Cardiovascular diseaseDiabetes mellitusCancerSickle cell diseaseHepatitis CChronic heart failureNeurodegenerative diseaseHemolytic anemia
05

Safety considerations

Hemolytic anemiaAcanthocytosisIncreased osmotic fragilityImpaired microvascular circulationOxidative damage to membrane proteins
06

Interacting drugs

Omega-3 fatty acids

8 more in the full profile.

07

Biomarkers

Omega-3 indexCholesterol-phospholipid (C/PL) ratioSphingomyelin/Phosphatidylcholine (SM/PC) ratioErythrocyte deformability indexMembrane saturation index (SI)

Beyond the preview

Go deeper on Red blood cell membrane lipid composition.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Red blood cell membrane lipid composition.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call